NFE2L2 and neurodegenerative disease: In particular, considering the reduction of NFE2L2 or PGAM5 in aging and human degenerative disease states [32–35], this NFE2L2-KEAP1-PGAM5 ternary interaction may be an important mechanism in the development of human diseases.